semaglutide drug mounjaro FDA approves new version of diabetes for weight loss Eli Lilly launches weight-loss drug

The company has a patient assistance program for people who qualify

While no large prospective studies have quantified SIBO incidence, the theoretical mechanism is plausible: prolonged small bowel transit time allows bacterial proliferation, producing bloating, pain, and diarrhea that mimics or worsens IBS-D

GLP-1 and Weight Loss GLP-1 medications are effective for weight loss when combined with healthy lifestyle changes

Many people with diabetes are blamed for their disease, which can cause shame and embarrassment this is a form of diabetes stigma

Insurers narrow eligibility for new weight loss medications Dr

The potential gut microbiota-mediated treatment options for liver cancer